Multiple intron retention occurs in tumor cell CD44 mRNA processing

American Journal of Pathology

Volumn 153, Issue 4, 1998, Pages 1221-1228

  Goodison, Steven ^a   Yoshida, Kazuhiro ^b   Churchman, Michael ^b   Tarin, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA;

ARTICLE; CHROMOSOME 11P; COLON TUMOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRON; METASTASIS POTENTIAL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA PROCESSING; SEQUENCE ANALYSIS;

EID: 0031685390     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65666-0     Document Type: Article

References (51)

1. Goodfellow PN, Banting G, Wiles MV, Tunnacliffe A, Parkar M, Solomon E, Dalchau R, Fabre JW: The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11. Eur J Immunol 1982, 12:659-663
2. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89:12160-12164
3. Tolg C, Hofmann M, Herrlich P, Ponta H: Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 1993, 21:1225-1229
4. Heider K-H, Dammrich J, Skroch-Angel P, Muller-Hermelink H-K, Vollmers HP, Herrlich P, Ponta H: Differential expression of CD44 splice variants in intestinal-and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Res 1993, 53:4197-4203
5. Yokozaki H, Ito R, Nakayama H, Kuniyasu H, Taniyama K, Tahara E: Expression of CD44 abnormal transcripts in human gastric carcinomas. Cancer Lett 1994, 83:229-234
6. Harn H-J, Ho L-I, Chang J-Y, Wu C-W, Jiang S-Y, Lee H-S, Lee W-H: Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects. Cancer 1995, 75:1065-1071
7. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992, 340:1053-1058
8. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 1993, 341:725-726
9. Mulder J-WR, Kruyt PM, Sewnath M, Oosting J, Seldenrijk CA, Weidema WF, Offenhaus GJA, Pals ST: Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet 1994, 344: 1470-1472
10. Wielenga VJM, Heider K-H, Offerhaus GJA, Adolf GR, van den Berg FM, Ponta H, Herrlich P, Pals ST: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993, 53:4754-4756
11. Kaufmann M, Heider K-H, Sinn H-P, von Minckwitz G, Ponta H, Herrlich P: CD44 isoforms in prognosis of breast cancer. Lancet 1995, 345:615-619
12. Dall P, Heider K-H, Sinn H-P, Skroch-Angel P, Adolf G, Kaufmann M, Herrlich P, Ponta H: Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int J Cancer 1995, 60:471-477
13. Dall P, Heider K-H, Hekele A, Minckwitz G, Kaufmann M, Ponta H, Herrlich P: Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Cancer Res 1994, 54:3337-3341
14. Matsumura Y, Hanbury D, Smith J, Tarin D: Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells. BMJ 1994, 308:619-624
15. Woodman AW, Sugiyama M, Yoshida K, Sugino T, Borgya A, Goodison S, Matsumura Y, Tarin D: Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am J Pathol 1996, 149:1519-1530
16. Penno MB, August JT, Baylin SB, Mabry M, Linnoila RI, Lee VS, Croteau D, Yang XL, Rosada C: Expression of CD44 in human lung tumors. Cancer 1994, 54:1381-1387
17. Koopman G, Heider K-H, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177:897-904
18. Matsumura Y, Sugiyama M, Matsumura S, Hayle AJ, Robinson P, Smith JC, Tarin D: Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities. J Pathol 1995, 177:11-20
19. Bolodeoku J, Yoshida K, Sugino T, Goodison S, Tarin D: Accumulation of immature intron-containing CD44 gene transcripts in breast cancer tissues. Mol Diagnostics 1996, 1:175-181
20. Yoshida K, Bolodeoku J, Sugino T, Goodison S, Matsumura Y, Warren BF, Toge T, Tahara E, Tarin D: Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res 1995, 55:4273-4277
21. Reed R, Maniatis T: The role of the mammalian branchpoint sequence in pre-mRNA splicing. Genes Dev 1988, 2:1268-1276
22. Goodison S, Yoshida K, Bolodeoku J, Woodman AW, Sugino T, Gorham H, Tarin D: Rapid analysis of distinctive CD44 RNA splicing preferences that characterize colonic tumors. Cancer Res 1997, 57: 3140-3144
23. Sugino T, Yoshida K, Zhao S, Goodison S, Tarin D: Disorderly CD44 expression in human cancer cells can be modulated by growth conditions. J Pathol 1998 (in press)
24. Michaud S, Reed R: A functional association between the 5′ and 3′ splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev 1993, 7:1008-1020
25. Kuivenhoven JA, Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G, Kastelein JJ: An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 1996, 98:358-364
26. Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar AK: Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolaemia and a common polymorphism. Hum Mol Genet 1996, 5:1325-1331
27. Nakai K, Sakamoto H: Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 1994, 141: 171-177
28. Jung M, Dritschilo A, Mark G, Kasid U: Identification of multiple repeat sequences and transcription-related elements within introns 4, 8 and 9 of human Raf-1. Biochem Biophys Res Comm 1993, 190:462-469
29. Brooks AR, Blackhart BD, Haubold K, Levy-Wilson B: Characterization of tissue-specific enhancer elements in the second intron of the human apolipoprotein B gene. J Biol Chem 1991, 266:7848-7859
30. Mohr G, Perlman PS, Lambowitz AM: Evolutionary relationships among group II intron-encoded proteins and identification of a conserved domain that may be related to maturase function. Nucleic Acids Res 1993, 21:4991-4997
31. Porter S, Mintz B: Multiple alternatively spliced transcripts of the mouse tyrosinase-encoding gene. Gene 1991, 97:277-282
32. Derwahl M, Seto P, Rapoport B: An abnormal splice donor site in one allele of the thyroid peroxidase gene in FRTL5 rat thyroid cells introduces a premature stop codon: association with the absence of functional enzymatic activity. Mol Endocrinol 1990, 4:793-799
33. Svoboda M, Ciccarelli E, Tastenoy M, Cauvin A, Stievenart M, Christopher J: Small introns in a hepatic cDNA encoding a new glucagon-like peptide 1-type receptor. Biochem Biophys Res Commun 1993, 191:479-486
34. Eiden MV, MacArthur I, Okayama H: Suppression of the chemically transformed phenotype of BHK cells by a human cDNA. Mol Cell Biol 1991, 11:5321-5329
35. Siebel CW, Rio DC: Regulated splicing of the Drosophila P transposable element third intron in vitro: somatic repression. Science 1990, 248:120-1208
36. Hampson RK, Rottman FM: Alternative processing of bovine growth hormone mRNA: nonsplicing of the final intron predicts a high molecular weight variant of bovine growth hormone. Proc Natl Acad Sci USA 1987, 84:2673-2677
37. Cooke NE, Ray J, Emery JG, Liebhaber SA: Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. J Biol Chem 1988, 263:9001-9006
38. Dirksen WP, Sun Q, Rottman FM: Multiple splicing signals control alternative intron retention of bovine growth hormone pre-mRNA. J Biol Chem 1995, 270:5346-5352
39. Legrain P, Rosbash M: Some cis-and trans-acting mutants for splicing target pre-mRNA to the cytoplasm. Cell 1989, 57:573-583
40. Hamm J, Mattaj IW: Monomethylated cap structures facilitate RNA export from the nucleus. Cell 1990, 63:109-118
41. van Leusden MR, Kuikman I, Sonnenberg A: The unique cytoplasmic domain of the human integrin variant β4E is produced by partial retention of intronic sequences. Biochem Biophys Res Commun 1997, 235:826-830
42. Altieri DC: Splicing of effector cell protease receptor-1 mRNA is modulated by an unusual retained intron. Biochemistry 1994, 33: 13848-13855
43. Tabiti K, Cui L, Chatwal VJ, Moochhala S, Ngoi SS, Fallen CJ: Novel alternative splicing predicts a secreted extracellular isoform of the human receptor-like protein tyrosine phosphatase LAR. Gene 1996, 175:7-13
44. Ebihara K, Masuhiro Y, Kitamoto T, Suzawa M, Uematsu Y, Yoshizawa T, Ono T, Harada H, Matsuda K, Hasegawa T: Intron retention generates a novel isoform of the murine vitamin D receptor that acts in a dominant negative way on the vitamin D signaling pathway. Mol Cell Biol 1996, 16:3393-3400
45. Gorham H, Sugino T, Woodman AW, Tarin D: Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal co-Ionic mucosa. J Clin Pathol 1996, 49:482-488
46. Lesley J, Hyman R, PW K: CD44 and its interaction with extracellular matrix. Adv Immunol 1993, 54:271-335
47. Stamenkovic I, Aruffo A, Amoiot M, Seed B: The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 1991, 10: 343-348
48. Seiter S, Arch R, Reber S, Komitowski D, Hoffmann M, Ponta H, Herrlich P, Matzku S, Zoller M: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 1993, 177:443-455
49. Gunthert U, Hoffman M, Rudy W, Reber S, Zoller M, Haufmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24
50. Hampson RK, LaFollette L, Rottman FM: Alternative processing of bovine growth hormone mRNA is influenced by downstream exon sequences. Mol Cell Biol 1989, 9:1604-1610
51. Dirksen WP, Hampson RK, Sun Q, Rottman FM: A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J Biol Chem 1994, 269:6431-6436